On October 12, 2022 Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics reported that it will discuss strategies for funding RNA-based cell therapies as a panel member at the RNA Cell Therapies Summit (Press release, Exacis Biotherapeutics, OCT 12, 2022, View Source [SID1234621927]). The panel discussion, "The Science Speaks for Itself – But What Else is Required to Secure an Investment," will include both medical and venture capital experts. Panelists will reveal what investors look for when investing in RNA-based cell therapies and share insights into how best to work holistically with scientists, investors, and lawyers to secure investments. Discussion will also include the role a founders legacy plays in investment opportunities.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

With experience as CEO and CMO of multiple pharmaceutical and biotechnology companies and C-suite advisor for several early-stage biotechnology companies, Dr. Fiore is uniquely qualified to provide his expert knowledge in raising capital to advance new therapeutics.

"While scientific discovery is vital to the development of novel treatment options, securing financial support is a critical requirement in progressing new therapeutics all the way through to patient delivery," said Dr. Fiore.

The panel will take place at 2:30 pm ET on Thursday, January 26, 2023.

The RNA Cell Therapies Summit will take place January 24-26, in Boston. The meeting will focus on specific challenges associated with RNA cell therapy development and how to accelerate these promising therapies through the value chain.